Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation.

Circulation 2007 Mar 5;115(10):1275-84. Epub 2007 Mar 5.

Department of Pediatrics, Division of Pediatric Cardiology, Stanford University School of Medicine, Stanford, CA 94305, USA.

Background: Patients with pulmonary arterial hypertension (PAH) have reduced expression of apolipoprotein E (apoE) and peroxisome proliferator-activated receptor-gamma in lung tissues, and deficiency of both has been linked to insulin resistance. ApoE deficiency leads to enhanced platelet-derived growth factor signaling, which is important in the pathobiology of PAH. We therefore hypothesized that insulin-resistant apoE-deficient (apoE-/-) mice would develop PAH that could be reversed by a peroxisome proliferator-activated receptor-gamma agonist (eg, rosiglitazone).

Methods And Results: We report that apoE-/- mice on a high-fat diet develop PAH as judged by elevated right ventricular systolic pressure. Compared with females, male apoE-/- were insulin resistant, had lower plasma adiponectin, and had higher right ventricular systolic pressure associated with right ventricular hypertrophy and increased peripheral pulmonary artery muscularization. Because male apoE-/- mice were insulin resistant and had more severe PAH than female apoE-/- mice, we treated them with rosiglitazone for 4 and 10 weeks. This treatment resulted in markedly higher plasma adiponectin, improved insulin sensitivity, and complete regression of PAH, right ventricular hypertrophy, and abnormal pulmonary artery muscularization in male apoE-/- mice. We further show that recombinant apoE and adiponectin suppress platelet-derived growth factor-BB-mediated proliferation of pulmonary artery smooth muscle cells harvested from apoE-/- or C57Bl/6 control mice.

Conclusions: We have shown that insulin resistance, low plasma adiponectin levels, and deficiency of apoE may be risk factors for PAH and that peroxisome proliferator-activated receptor-gamma activation can reverse PAH in an animal model.

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.106.663120DOI Listing
March 2007
72 Reads
133 Citations
14.430 Impact Factor

Publication Analysis

Top Keywords

apoe-/- mice
20
proliferator-activated receptor-gamma
16
peroxisome proliferator-activated
16
male apoe-/-
12
insulin resistance
12
pulmonary artery
12
plasma adiponectin
12
systolic pressure
8
ventricular systolic
8
platelet-derived growth
8
develop pah
8
receptor-gamma activation
8
reversed peroxisome
8
insulin resistant
8
artery muscularization
8
arterial hypertension
8
muscularization male
8
pulmonary arterial
8
linked insulin
8
pah
8

Altmetric Statistics

The Emergence of Digital Opinion Leaders + Blood Cancer DOL Dashboard

This month we’ve pulled together a dashboard of 20 of the most impactful Digital Opinion Leaders (DOLs) related to Blood Cancers. Please take a live look at the DOL Board for this group of experts.

Read Article

Similar Publications